product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
LATS2 (D83D6) Rabbit mAb
catalog :
5888S
quantity :
100 ul
price :
235 USD
clonality :
monoclonal
host :
rabbit
reactivity :
human
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 4
Published Application/Species/DilutionReference
  • western blot; human; fig 3
Kim M, Kim M, Park S, Lee C, Lim D. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. EMBO Rep. 2016;17:64-78 pubmed publisher
  • western blot; human; fig 5
Chen X, Stauffer S, Chen Y, Dong J. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis. J Biol Chem. 2016;: pubmed
  • western blot; human; 1:1000; fig 1
Meng Z, Moroishi T, Mottier-Pavie V, Plouffe S, Hansen C, Hong A, et al. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun. 2015;6:8357 pubmed publisher
  • western blot; human; fig 3
Kim M, Kim M, Lee M, Kim C, Lim D. The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis. Nat Commun. 2014;5:5370 pubmed publisher
product information
SKU :
5888S
Product-Name :
LATS2 (D83D6) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, (Mk)
Applications :
Western blot
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
150
Host :
Rabbit
Target :
LATS2
Primary-Protein :
LATS2
Alt-Names :
FLJ13161,KPM,Kinase phosphorylated during mitosis protein,LATS (large tumor suppressor, Drosophila) homolog 2,LATS, large tumor suppressor, homolog 2 (Drosophila),LATS2,Large tumor suppressor homolog 2,Serine/threonine-protein kinase LATS2,Serine/threonine-protein kinase kpm,Warts-like kinase,serine/threonine kinase KPM
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.